Literature DB >> 1562858

New treatments for erectile impotence.

A Gregoire1.   

Abstract

The range of interventions available for the treatment of erectile failure has increased in the past ten years. A significant development is intracavernosal injection of vasoactive drugs, but this treatment is far from ideal. Other, less invasive, pharmacological interventions are being investigated; as yet, none of these appear effective enough to have any significant clinical impact. External vacuum devices are a viable option for some patients, and penile prostheses have become increasingly sophisticated, although research examining their benefits has not. The range of available treatment methods and the growing complexity of the assessment for erectile problems demands an eclecticism of approach which can best be provided by multidisciplinary clinics specialising in sexual dysfunctions.

Entities:  

Mesh:

Year:  1992        PMID: 1562858     DOI: 10.1192/bjp.160.3.315

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  3 in total

1.  Viagra: on release. Evidence on the effectiveness of sildenafil is good.

Authors:  A Gregoire
Journal:  BMJ       Date:  1998-09-19

Review 2.  Sildenafil: a review of its use in erectile dysfunction.

Authors:  H D Langtry; A Markham
Journal:  Drugs       Date:  1999-06       Impact factor: 9.546

Review 3.  Intracavernous alprostadil. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in erectile dysfunction.

Authors:  A P Lea; H M Bryson; J A Balfour
Journal:  Drugs Aging       Date:  1996-01       Impact factor: 3.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.